{"transactions":[{"id":3327065,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":152729,"kind":"person","name":"Johnson Gordon K","position":1,"cik":"0001638367","reported_name":"Johnson Gordon K","relationship":{"officer":true,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2020-01-02T21:45:59.000Z","date":"2019-12-31","kind":"purchase","acquired":true,"shares":10000,"price":0.3884,"value":3884.0,"ownership":{"direct":true},"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001437749-20-000071","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774920000071/rdgdoc.xml","form_type":"4"}},{"id":3327064,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":152729,"kind":"person","name":"Johnson Gordon K","position":1,"cik":"0001638367","reported_name":"Johnson Gordon K","relationship":{"officer":true,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2020-01-02T21:45:59.000Z","date":"2019-12-31","kind":"purchase","acquired":true,"shares":10000,"price":0.39,"value":3900.0,"ownership":{"direct":true},"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001437749-20-000071","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774920000071/rdgdoc.xml","form_type":"4"}},{"id":3357361,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":152729,"kind":"person","name":"Johnson Gordon K","position":1,"cik":"0001638367","reported_name":"Johnson Gordon K","relationship":{"officer":true,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-11-27T21:15:31.000Z","date":"2019-11-25","kind":"grant","acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a stock option under the Issuer's 2014 Equity Incentive Plan (the \"Plan\"). 100% of the shares underlying the option will vest upon the acceptance of a new drug application for the Company's product candidate, KP415, by the U.S. Food and Drug Administration, provided that at the relevant vesting date such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant."}],"balance_after":36000,"derivative":{"exercise_price":0.5161,"expiration_date":"2029-11-24","underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001437749-19-023645","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774919023645/rdgdoc.xml","form_type":"4"}},{"id":3419479,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":152729,"kind":"person","name":"Johnson Gordon K","position":1,"cik":"0001638367","reported_name":"Johnson Gordon K","relationship":{"officer":true,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-09-09T20:12:58.000Z","date":"2019-09-09","kind":"purchase","acquired":true,"shares":5000,"price":0.8251,"value":4125.5,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001437749-19-018071","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774919018071/rdgdoc.xml","form_type":"4"}},{"id":3419478,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":152729,"kind":"person","name":"Johnson Gordon K","position":1,"cik":"0001638367","reported_name":"Johnson Gordon K","relationship":{"officer":true,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-09-09T20:12:58.000Z","date":"2019-09-09","kind":"purchase","acquired":true,"shares":3000,"price":0.8032,"value":2409.6,"ownership":{"direct":true},"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001437749-19-018071","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774919018071/rdgdoc.xml","form_type":"4"}},{"id":3419477,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":152729,"kind":"person","name":"Johnson Gordon K","position":1,"cik":"0001638367","reported_name":"Johnson Gordon K","relationship":{"officer":true,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-09-09T20:12:58.000Z","date":"2019-09-09","kind":"purchase","acquired":true,"shares":2000,"price":0.8165,"value":1633.0,"ownership":{"direct":true},"balance_after":12000,"source":{"system":"sec-edgar","filing":"0001437749-19-018071","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774919018071/rdgdoc.xml","form_type":"4"}},{"id":3645654,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":152729,"kind":"person","name":"Johnson Gordon K","position":1,"cik":"0001638367","reported_name":"Johnson Gordon K","relationship":{"officer":true,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-20T21:26:00.000Z","date":"2019-02-18","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a stock option under the Issuer's 2014 Equity Incentive Plan (the \"Plan\"). 25% of the shares will vest on February 18, 2020 and the remaining 75% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant."}],"balance_after":60000,"derivative":{"exercise_price":2.29,"expiration_date":"2029-02-17","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001437749-19-002953","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774919002953/rdgdoc.xml","form_type":"4"}},{"id":3667974,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":152729,"kind":"person","name":"Johnson Gordon K","position":1,"cik":"0001638367","reported_name":"Johnson Gordon K","relationship":{"officer":true,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-09T00:28:43.000Z","date":"2019-02-06","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a stock option under the Issuer's 2014 Equity Incentive Plan (the \"Plan\"). 25% of the shares will vest on February 6, 2020 and the remaining 75% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant."}],"balance_after":100000,"derivative":{"exercise_price":2.66,"expiration_date":"2029-02-05","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001437749-19-002181","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774919002181/rdgdoc.xml","form_type":"4"}},{"id":3791924,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":152729,"kind":"person","name":"Johnson Gordon K","position":1,"cik":"0001638367","reported_name":"Johnson Gordon K","relationship":{"officer":true,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2018-10-12T20:12:20.000Z","date":"2018-10-12","kind":"purchase","acquired":true,"shares":1000,"price":2.61,"value":2610.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001437749-18-018242","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774918018242/rdgdoc.xml","form_type":"4"}},{"id":3791923,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":152729,"kind":"person","name":"Johnson Gordon K","position":1,"cik":"0001638367","reported_name":"Johnson Gordon K","relationship":{"officer":true,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2018-10-12T20:12:20.000Z","date":"2018-10-10","kind":"purchase","acquired":true,"shares":1000,"price":2.6466,"value":2646.6,"ownership":{"direct":true},"balance_after":9000,"source":{"system":"sec-edgar","filing":"0001437749-18-018242","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774918018242/rdgdoc.xml","form_type":"4"}},{"id":3791922,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":152729,"kind":"person","name":"Johnson Gordon K","position":1,"cik":"0001638367","reported_name":"Johnson Gordon K","relationship":{"officer":true,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2018-10-12T20:12:20.000Z","date":"2018-10-10","kind":"purchase","acquired":true,"shares":2000,"price":2.6,"value":5200.0,"ownership":{"direct":true},"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001437749-18-018242","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774918018242/rdgdoc.xml","form_type":"4"}},{"id":4086463,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":152729,"kind":"person","name":"Johnson Gordon K","position":1,"cik":"0001638367","reported_name":"Johnson Gordon K","relationship":{"officer":true,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-01-29T23:56:31.000Z","date":"2018-01-25","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a stock option under the Issuer's 2014 Equity Incentive Plan (the \"Plan\"). 25% of the shares will vest on January 25, 2019 and the remaining 75% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant."}],"balance_after":75000,"derivative":{"exercise_price":5.5,"expiration_date":"2028-01-24","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001437749-18-001304","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774918001304/rdgdoc.xml","form_type":"4"}},{"id":4224465,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":152729,"kind":"person","name":"Johnson Gordon K","position":1,"cik":"0001638367","reported_name":"Johnson Gordon K","relationship":{"officer":true,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2017-08-25T20:31:37.000Z","date":"2017-08-24","kind":"purchase","acquired":true,"shares":1000,"price":2.6264,"value":2626.4,"ownership":{"direct":true},"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001437749-17-015334","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774917015334/rdgdoc.xml","form_type":"4"}},{"id":4224464,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":152729,"kind":"person","name":"Johnson Gordon K","position":1,"cik":"0001638367","reported_name":"Johnson Gordon K","relationship":{"officer":true,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2017-08-25T20:31:37.000Z","date":"2017-08-24","kind":"purchase","acquired":true,"shares":2000,"price":2.6137,"value":5227.4,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001437749-17-015334","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774917015334/rdgdoc.xml","form_type":"4"}},{"id":4224463,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":152729,"kind":"person","name":"Johnson Gordon K","position":1,"cik":"0001638367","reported_name":"Johnson Gordon K","relationship":{"officer":true,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2017-08-25T20:31:37.000Z","date":"2017-08-24","kind":"purchase","acquired":true,"shares":1000,"price":2.55,"value":2550.0,"ownership":{"direct":true},"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001437749-17-015334","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774917015334/rdgdoc.xml","form_type":"4"}},{"id":4475252,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":152729,"kind":"person","name":"Johnson Gordon K","position":1,"cik":"0001638367","reported_name":"Johnson Gordon K","relationship":{"officer":true,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-01-31T22:02:08.000Z","date":"2017-01-27","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a stock option under the Issuer's 2014 Equity Incentive Plan (the \"Plan\"). 25% of the shares will vest on January 27, 2018 and the remaining 75% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant."}],"balance_after":75000,"derivative":{"exercise_price":3.55,"expiration_date":"2027-01-26","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001437749-17-001391","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774917001391/rdgdoc.xml","form_type":"4"}}]}